ACCESS Newswire

TIS Appoints New CEO to Accelerate Global Growth

26.1.2026 14:00:00 EET | ACCESS Newswire | Press release

Share

BERLIN, DE / ACCESS Newswire / January 26, 2026 / Treasury Intelligence Solutions (TIS), a leading cloud-based platform for payments and cash management, today announced Zlatko Vucetic as the new Chief Executive Officer (CEO) effective from February 1, 2026. This move comes as a pivotal step in advancing the company's long-term vision and global growth strategy in cloud-native cash management, liquidity, and payment solutions.

As an experienced CEO, Zlatko brings a strong track record in scaling software companies across Europe, Asia, and the U.S., combined with deep expertise in driving innovation and accelerating growth in competitive markets. Zlatko will lead TIS in its journey to be a market leader in payment and liquidity management across Europe and North America.

After five successful years as CEO, Erik Masing will transition into the role of Vice Chair of the Board, where he will continue to provide strategic guidance and support. Under Erik's leadership, TIS achieved significant milestones, including the strategic acquisition of Cashforce, which expanded the company's portfolio and strengthened its position in the global payments and cash management market. Joerg Wiemer, TIS co-founder and former CEO, will remain actively involved, ensuring continuity and leveraging his deep industry expertise to support TIS's long-term vision.

Zlatko is a seasoned technology executive with extensive leadership experience in the enterprise software space. Most recently, he served as CEO of Infront AS, a leading European provider of financial market data solutions, including trading and wealth management technology. Prior to this, he was CEO of FocusVision, a U.S.-based market research and customer insights software platform. Earlier in his career, Zlatko spent nearly a decade in senior leadership at Saxo Bank, a leading online trading and investment firm.

Commenting on his appointment, Zlatko said:

"TIS has built a strong foundation as a trusted partner for CFOs, treasurers and finance teams worldwide. Our mission is clear: to help the entire office of the CFO manage liquidity and payments on a global scale. We will double down on innovation, accelerate our international footprint, and deliver solutions that not only meet today's challenges but anticipate tomorrow's. With the best-in-class products and the strength of our team, I'm confident TIS will set the standard for this industry."

About TIS

TIS helps CFOs, Treasurers, and Finance teams transform their global cash flow, liquidity, and payment functions. Since 2010, our award-winning cloud platform and best-in-class service model have empowered the entire office of the CFO to collaborate more effectively and attain maximum efficiency, automation, and control. TIS enables users to achieve superior performance in key areas surrounding cash forecasting, working capital, outbound payments, financial messaging, fraud prevention, payment compliance, and more.

For more information, visit tispayments.com and begin reimagining your approach to global cash flow, liquidity, and payments.

Contact:

Thomas Müllertz
Chief Marketing Officer
+4520989479
thomas.mullertz@tispayments.com

SOURCE: Treasury Intelligence Solutions

View the original press release on ACCESS Newswire

Treasury Intelligence Solutions

Subscribe to releases from ACCESS Newswire

Subscribe to all the latest releases from ACCESS Newswire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from ACCESS Newswire

AGFA HealthCare Named Best in KLAS(R) 2026 Across Three Enterprise Imaging Segments in the United States4.2.2026 16:45:00 EET | Press release

Industry recognition for the third consecutive year reinforces AGFA HealthCare's clinician-first commitment, and leadership in empowering connected, high-performance imaging environments MORTSEL, BE / ACCESS Newswire / February 4, 2026 / AGFA HealthCare today announced that it has been named Best in KLAS® 2026 across three Enterprise Imaging segments in the United States, with two awards earned for the second consecutive year, underscoring the company's continued leadership in delivering clinician-first imaging solutions trusted by healthcare organizations worldwide. The recognition comes as KLAS Research marks its 30th anniversary, celebrating three decades of amplifying the voice of healthcare providers through independent, data-driven insights. AGFA HealthCare's Best in KLAS distinctions reflect strong customer validation of its Enterprise Imaging platform - designed to empower clinicians to stay in their flow, reduce complexity across imaging workflows, and enable confident clinica

Karbon-X Files Quarterly Report on Form 10-Q Highlighting Strong Revenue Growth and Commercial Scale4.2.2026 16:00:00 EET | Press release

CALGARY, AB / ACCESS Newswire / February 4, 2026 / Karbon-X Corp. (OTCQX:KARX) ("Karbon-X" or the "Company"), a vertically integrated climate solutions company, today announced that it has filed its Quarterly Report on Form 10-Q for the six months ended November 30, 2025. The filing highlights continued momentum in Karbon-X's commercial operations, driven by significant revenue growth and the expansion of its global carbon activities across both compliance and voluntary markets. "Over the past several quarters, we transformed Karbon-X from a developing platform into a scaled, revenue-generating global operator," said Chad Clovis, Chief Executive Officer of Karbon-X Corp. "Revenue increased to $56.5 million (USD), compared to $1.3 million (USD) in the prior-year period, reflecting the strength of our commercial strategy and the growing demand for high-integrity carbon solutions. As we continue to invest in scaling our operations, our expanding global footprint, improved profitability, a

CHAR Technologies Licenses High-Temperature Pyrolysis Technology to GazoTech SAS for Entry Into European Markets4.2.2026 15:00:00 EET | Press release

TORONTO, ON / ACCESS Newswire / February 4, 2026 / CHAR Technologies Ltd. ("CHAR Tech" or "the Company") (TSXV:YES)(FSE:68K) a leader in sustainable biomass energy solutions, today announced that it has entered into a formal technology know-how licensing agreement with GazoTech SAS ("GazoTech"), a France-based energy developer, to support deployment of CHAR Tech's technology in France and selected European markets. The agreement follows recent commissioning progress at CHAR Tech's Thorold Renewable Energy Facility and complements the Company's ongoing development of larger-scale projects in North America. Under the agreement, CHAR Tech is the licensor of its proprietary High-Temperature Pyrolysis ("HTP") technology, granting GazoTech a know-how licence for projects developed in France as well as certain additional European markets, subject to project-by-project application of the licenced technology. GazoTech has multiple projects in development in France, notably: An industrial integr

Axon Neuroscience's Immunotherapy Selected for a Landmark Combination-Therapy Alzheimer’s Clinical Trial in US, Supported by a USD 151 Million Grant4.2.2026 15:00:00 EET | Press release

Axon Neuroscience's active tau immunotherapy AADvac1 has been selected as the first tau-targeted therapy to enter a groundbreaking U.S. Alzheimer's disease phase 2 clinical trial (supported by a USD 151 million grant) and, simultaneously, a new platform trial for progressive supranuclear palsy (PSP) (supported by a USD 75 million grant) SAN FRANCISCO, CA / ACCESS Newswire / February 4, 2026 / Axon Neuroscience, a global leader in immunotherapy for human neurodegenerative diseases with an internationally recognized scientific team, announces the achievement of two historic milestones with the potential to significantly influence the future treatment of Alzheimer's disease and progressive supranuclear palsy (PSP): 1. AADvac1 Selected as the First Tau Therapy in the Phase 2 Alzheimer's Tau Platform (ATP) Combination-Therapy Trial An independent panel of leading U.S. scientific and clinical experts selected AADvac1 as the first therapy targeting pathological tau protein to be evaluated in

Formerra and Evonik Expand Distribution Partnership for Healthcare Grades2.2.2026 16:00:00 EET | Press release

Agreement Expands Access to Evonik's CARE Brand Medical Grades in the U.S. and Canada ROMEOVILLE, ILLINOIS / ACCESS Newswire / February 2, 2026 / Formerra, a leader in performance materials distribution, today announced an expanded distribution agreement that brings Evonik's CARE brand healthcare grades into Formerra's medical portfolio. Covering the United States and Canada, the agreement creates new access points for high-performance polyamides used in essential healthcare applications. This expansion kicks off at MD&M West 2026 this week, and underscores both companies' commitment to supporting the healthcare market with high-performance materials, responsive service, and continuity of supply. It also builds on the companies' two-year partnership, which introduced Evonik's VESTAMID® and TROGAMID® families to Formerra's engineered materials lineup. With this expansion, Formerra will support Evonik healthcare grades designed for fluid handling, drug delivery, diagnostic systems, surgi

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye